Lupartumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Lupartumab Usage And Synthesis

Uses

Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980[1].

References

[1] Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May;16(5):893-904. DOI:10.1158/1535-7163.MCT-16-0474

Lupartumab(1640971-88-5)Related Product Information

• Indatuximab Ravtansine
• Research Grade Acazicolcept (DHC83404)
• Perakizumab
• Murlentamab
• Teclistamab
• Vanucizumab
• Icrucumab
• Vopratelimab
• Tarcocimab
• Romlusevimab